Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism
- PMID: 7706942
Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism
Abstract
A multicompartmental model has been devised to explain apolipoprotein B (apoB) kinetics in very low density lipoprotein subfractions (VLDL1 Sf 60-400 and VLDL2 Sf 20-60), intermediate density (IDL Sf 12-20) and low density lipoproteins (LDL Sf 0-12). Normal and hyperlipemic subjects were given tracer doses of 131I-labeled VLDL1 and 125I-labeled VLDL2 and the metabolism of apoB in VLDL1, VLDL2, IDL, and LDL was followed over a period of 13 days. VLDL1 apoB and VLDL2 apoB clearance curves had an initial shoulder, a rapid decay, and a 'tail' of slowly metabolized lipoprotein. ApoB derived from VLDL1 appeared in IDL over 10-50 h and exhibited bi-exponential decay that was attributed to the presence of two metabolically distinct species. A further compartment was required to explain the observation that a substantial proportion of apoB from VLDL2 appeared and disappeared from the IDL density range faster than apoB derived from VLDL1 delipidation. Both of the more rapidly removed IDL species gave rise to LDL apoB that was also modeled as a heterogeneous entity with two plasma compartments. The final model, which has much in common with previous versions (M. Berman et al. 1978. J. Lipid Res. 19: 38-56), a multi-step delipidation pathway and slowly metabolized remnant compartments in VLDL, incorporates parallel delipidation routes in VLDL2, IDL, and LDL. These parallel pathways linked kinetic heterogeneity in VLDL with that in IDL and LDL.
Similar articles
-
Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins.J Lipid Res. 1995 Jan;36(1):158-71. J Lipid Res. 1995. PMID: 7706941
-
Model development to describe the heterogeneous kinetics of apolipoprotein B and triglyceride in hypertriglyceridemic subjects.J Lipid Res. 1991 May;32(5):743-62. J Lipid Res. 1991. PMID: 2072038
-
Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.Diabetes. 1990 Sep;39(9):1017-27. doi: 10.2337/diab.39.9.1017. Diabetes. 1990. PMID: 2200727
-
In vivo studies of VLDL metabolism and LDL heterogeneity.Eur Heart J. 1998 Jul;19 Suppl H:H7-10. Eur Heart J. 1998. PMID: 9717058 Review.
-
De novo production of low density lipoproteins: fact or fancy.J Lipid Res. 1991 Jul;32(7):1099-112. J Lipid Res. 1991. PMID: 1940634 Review.
Cited by
-
Bariatric surgery improves postprandial VLDL kinetics and restores insulin-mediated regulation of hepatic VLDL production.JCI Insight. 2023 Aug 22;8(16):e166905. doi: 10.1172/jci.insight.166905. JCI Insight. 2023. PMID: 37432744 Free PMC article.
-
Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles.World J Gastroenterol. 2016 Aug 7;22(29):6716-25. doi: 10.3748/wjg.v22.i29.6716. World J Gastroenterol. 2016. PMID: 27547014 Free PMC article.
-
Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size.J Lipid Res. 2009 Dec;50(12):2398-411. doi: 10.1194/jlr.M800354-JLR200. Epub 2009 Jun 10. J Lipid Res. 2009. PMID: 19515990 Free PMC article.
-
Associations between Endothelial Lipase and Apolipoprotein B-Containing Lipoproteins Differ in Healthy Volunteers and Metabolic Syndrome Patients.Int J Mol Sci. 2023 Jun 26;24(13):10681. doi: 10.3390/ijms241310681. Int J Mol Sci. 2023. PMID: 37445857 Free PMC article.
-
Diagnostic markers based on a computational model of lipoprotein metabolism.J Clin Bioinforma. 2011 Oct 26;1(1):29. doi: 10.1186/2043-9113-1-29. J Clin Bioinforma. 2011. PMID: 22029862 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous